Independent education resourceInformation here does not replace care from a qualified health professional.
Peptide Therapy GuideClear peptide education

Understand the source comparison

Best Research Peptides for Insomnia: Mechanism Comparison

DSIP Modulates thalamic delta wave generation via calcium channel stabilization Stage 3 slow-wave sleep 20–40 minutes post-administration Most direct sleep-inducing mechanism. Increases slow-wave sleep without REM suppression or rebound insomnia Epithalon Upre

No winner is assigned.

This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.

  • DSIP
  • Modulates thalamic delta wave generation via calcium channel stabilization
  • Stage 3 slow-wave sleep
  • 20–40 minutes post-administration
  • Most direct sleep-inducing mechanism. Increases slow-wave sleep without REM suppression or rebound insomnia
  • Epithalon
  • Upregulates circadian clock genes (BMAL1, CLOCK) and restores pineal melatonin synthesis
  • Circadian rhythm entrainment, sleep onset
  • 10–14 days for full effect
  • Best for circadian misalignment and age-related melatonin decline. Effects persist 60–90 days post-treatment
  • Selank
  • Enhances GABAergic and serotonergic signaling, reduces evening cortisol
  • Sleep onset latency in anxiety-driven insomnia
  • 30–60 minutes (anxiolytic effects); 7–10 days (sustained sleep improvement)
  • Ideal for stress-related insomnia. Reduces sleep latency without daytime sedation or dependency risk
  • BPC-157
  • Reduces neuroinflammation, stabilizes blood-brain barrier, modulates serotonin-dopamine axis
  • Sleep consolidation, reduces nocturnal awakenings
  • 3–7 days for neuroinflammatory reduction
  • Best for insomnia secondary to chronic pain or systemic inflammation. Indirect sleep benefit through CNS repair
  • GHRP-2 / Ipamorelin
  • Amplifies endogenous GH pulses during slow-wave sleep
  • Stage 3/4 deep sleep, GH-dependent recovery
  • 30–60 minutes pre-sleep dosing
  • Enhances sleep quality in GH-deficient states. Particularly effective in aging populations with flattened GH secretion
  • MK-677
  • Ghrelin receptor agonist. Increases GH, IGF-1, and orexin signaling
  • REM sleep and Stage 4 sleep
  • 2–3 weeks for full sleep architecture changes
  • Oral bioavailability advantage. Sustained 24-hour effect improves sleep consolidation without injection